BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7746020)

  • 1. [The treatment of cyclosporine A-resistant pyoderma gangrenosum with recombinant interferon alfa-2].
    Sánchez Román J; Castillo Palma MJ; Ocaña Medina C; Rodríguez Cañas T
    Med Clin (Barc); 1995 Apr; 104(13):517-8. PubMed ID: 7746020
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyoderma gangrenosum in a patient with cryoglobulinemia and hepatitis C successfully treated with interferon alfa.
    Smith JB; Shenefelt PD; Soto O; Valeriano J
    J Am Acad Dermatol; 1996 May; 34(5 Pt 2):901-3. PubMed ID: 8621825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pyoderma gangrenosum--an interdisciplinary diagnostic problem].
    Torzecka JD; Kondras K; Dziankowska-Bartkowiak B; Waszczykowska E; Modzelewski B; Jurałowicz P; Kondras M
    Pol Merkur Lekarski; 2008 Jan; 24(139):34-7. PubMed ID: 18634250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Er: YAG Laser Ablation: An Adjuvant Treatment for Medically Resistant Pyoderma Gangrenosum.
    Çalişkan E
    Dermatol Surg; 2017 Nov; 43(11):1405-1407. PubMed ID: 28272082
    [No Abstract]   [Full Text] [Related]  

  • 5. Intractable wounds caused by pyoderma gangrenosum in a patient with critical limb ischemia treated with cyclosporine and adjuvant sympathectomy.
    Takahashi Y; Yamaguchi Y; Itoh K; Sano S; Morita A; Katayama I
    Dermatol Surg; 2009 Apr; 35(4):699-703. PubMed ID: 19309343
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel therapy for the treatment of pyoderma gangrenosum.
    Azizan NZ; Gangaram HB; Hussein SH
    Med J Malaysia; 2008 Mar; 63(1):51-4. PubMed ID: 18935734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum.
    Seishima M; Mizutani Y; Shibuya Y; Nagasawa C; Aoki T
    Ther Apher Dial; 2007 Jun; 11(3):177-82. PubMed ID: 17497998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression.
    de Imus G; Golomb C; Wilkel C; Tsoukas M; Nowak M; Falanga V
    J Am Acad Dermatol; 2001 Jan; 44(1):61-6. PubMed ID: 11148478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of chronic hepatitis B with interferon alfa-2b (Intron A)].
    Cianciara J; Laskus T; Hryniewicz H; Jabłońska J; Loch T
    Przegl Epidemiol; 1991; 45(4):315-20. PubMed ID: 1841409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyoderma gangrenosum and its treatment.
    Powell RJ; Holbrook MR; Stevens A
    Lancet; 1997 Dec; 350(9093):1720-1. PubMed ID: 9413459
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement of ulcerative pyoderma gangrenosum with hyperbaric oxygen therapy.
    Mazokopakis EE; Kofteridis DP; Pateromihelaki AT; Vytiniotis SD; Karastergiou PG
    Dermatol Ther; 2011; 24(1):134-6. PubMed ID: 21276167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyoderma gangrenosum: a misdiagnosis.
    El-Kehdy J; Haneke E; Karam PG
    J Drugs Dermatol; 2013 Feb; 12(2):228-30. PubMed ID: 23377399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case study: diagnosis and treatment of pyoderma gangrenosum.
    Burton J
    Br J Nurs; 2005 Sep 8-21; 14(16):S10-3. PubMed ID: 16215496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: Treatment-resistant pyoderma gangrenosum.
    Kosari P; Feldman SR
    Dermatol Online J; 2012 Apr; 18(4):8. PubMed ID: 22559023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease.
    Carp JM; Onuma E; Das K; Gottlieb AB
    Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pyoderma gangrenosum with cyclosporine.
    Matis WL; Ellis CN; Griffiths CE; Lazarus GS
    Arch Dermatol; 1992 Aug; 128(8):1060-4. PubMed ID: 1497359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte adsorption apheresis for the treatment of pyoderma gangrenosum.
    Watanabe Y; Yamada H
    J Dermatol; 2008 Dec; 35(12):792-4. PubMed ID: 19239562
    [No Abstract]   [Full Text] [Related]  

  • 19. Pyoderma gangrenosum coexisting with acute myelogenous leukaemia.
    Krauze E; Brzezińska-Wcisło L; Kamińska-Winciorek G; Wygledowska-Kania M; Sygula E
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):589-92. PubMed ID: 16164714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperbaric oxygen therapy as an adjuvant treatment for pyoderma gangrenosum].
    Herfarth AE; Martínez-Ramos D; Nomdedeu-Guinot J; Salvador-Sanchis JL
    Cir Esp; 2009 May; 85(5):319-21. PubMed ID: 19375074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.